Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chang, Shu Chun ^a   Vivian Yang, Wei Chung ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; GLUCOSE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PERLECAN; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERGLYCEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TROPHOBLAST; UPREGULATION;

EID: 84881533767     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/457971     Document Type: Article

References (42)

1. Leach L., Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 2011 18 4 263 269 2-s2.0-79955126231 10.1111/j.1549-8719.2011.00091.x
2. Ferreira A. M., Rollins B. J., Faunce D. E., Burns A. L., Zhu X., Dipietro L. A., The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 2005 30 2 64 71 (Pubitemid 40432631)
3. Gustafsson E., Almonte-Becerril M., Bloch W., Costell M., Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro. PLoS One 2013 8 1 e53715
4. Aviezer D., Hecht D., Safran M., Elsinger M., David G., Yayon A., Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994 79 6 1005 1013 2-s2.0-0028579734
5. Saksela O., Moscatelli D., Sommer A., Rifkin D. B., Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. Journal of Cell Biology 1988 107 2 743 751 2-s2.0-0023687871
6. Carson D. D., DeSouza M. M., Regisford E. G. C., Mucin and proteoglycan functions in embryo implantation. BioEssays 1998 20 7 577 583 2-s2.0-0032127948 (Pubitemid 28362304)
7. Raboudi N., Julian J., Rohde L. H., Carson D. D., Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95). Journal of Biological Chemistry 1992 267 17 11930 11939 2-s2.0-0026710619
8. Liu S., Smith S. E., Julian J., Rohde L. H., Karin N. J., Carson D. D., cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines. Journal of Biological Chemistry 1996 271 20 11817 11823 2-s2.0-15844396909 10.1074/jbc.271.20.11817 (Pubitemid 26157252)
9. Rohde L. H., Julian J., Babaknia A., Carson D. D., Cell surface expression of HIP, a novel heparin/heparan sulfatebinding protein, of human uterine epithelial cells and cell lines. Journal of Biological Chemistry 1996 271 20 11824 11830 2-s2.0-0029948527
10. Yang W.-C. V., Su T.-H., Yang Y.-C., Chang S.-C., Chen C.-Y., Chen C.-P., Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 2005 26 10 780 788 2-s2.0-27544513842 10.1016/j.placenta. 2004.11.002 (Pubitemid 41535485)
11. Chen C.-P., Chang S.-C., Vivian Yang W.-C., High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 2007 28 2-3 97 106 2-s2.0-33845502506 10.1016/j.placenta.2006.02.009 (Pubitemid 44914524)
12. Huppertz B., The anatomy of the normal placenta. Journal of Clinical Pathology 2008 61 12 1296 1302 2-s2.0-57549114322 10.1136/jcp.2008.055277
13. Knofler M., Critical growth factors and signalling pathways controlling human trophoblast invasion. The International Journal of Developmental Biology 2010 54 2-3 269 280
14. Fischer D.-C., Haubeck H.-D., Eich K., Kolbe-Busch S., Stöcker G., Stuhlsatz H. W., Greiling H., A novel keratan sulphate domain preferentially expressed on the large aggregating proteoglycan from human articular cartilage is recognized by the monoclonal antibody 3D12/H7. Biochemical Journal 1996 318 3 1051 1056 2-s2.0-0029767030 (Pubitemid 26320976)
15. Doolittle M. H., Martin D. C., Davis R. C., Reuben M. A., Elovson J., A two-cycle immunoprecipitation procedure for reducing nonspecific protein contamination. Analytical Biochemistry 1991 195 2 364 368 2-s2.0-0025736627
16. Fröhlich J. D., Huppertz B., Abuja P. M., König J., Desoye G., Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia. American Journal of Pathology 2012 180 1 153 164 2-s2.0-83455164916 10.1016/j.ajpath.2011.09.012
17. Jain M., Logerfo F. W., Guthrie P., Pradhan L., Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells. Journal of Vascular Surgery 2011 53 6 1654.e2 1660.e2 2-s2.0-79957518176 10.1016/j.jvs.2011.02.019
18. Castorina A., Giunta S., Mazzone V., Cardile V., D'Agata V., Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells. Peptides 2010 31 12 2276 2283 2-s2.0-78049469157 10.1016/j.peptides.2010.08.013
19. Duan W., Paka L., Pillarisetti S., Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis. Cardiovascular Diabetology 2005 4, article 16 2-s2.0-27644474139 10.1186/1475-2840-4-16 (Pubitemid 41554913)
20. Hulme C. H., Westwood M., Myers J. E., Heazell A. E., A high-throughput colorimetric-assay for monitoring glucose consumption by cultured trophoblast cells and placental tissue. Placenta 2012 33 11 949 951
21. Pradhan L., Nabzdyk C., Andersen N. D., LoGerfo F. W., Veves A., Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Reviews in Molecular Medicine 2009 11 2009e2 2-s2.0-63049106661 10.1017/S1462399409000945
22. Pradhan L., Cai X., Wu S., Andersen N. D., Martin M., Malek J., Guthrie P., Veves A., Logerfo F. W., Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. Journal of Surgical Research 2011 167 2 336 342 2-s2.0-79954590766 10.1016/j.jss.2009.09.012
23. Ferreira A. M., Rollins B. J., Faunce D. E., Burns A. L., Zhu X., DiPietro L. A., The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 2005 30 2 64 71 2-s2.0-15944411720 10.1016/j.cyto.2004.12.006 (Pubitemid 40432631)
24. Waehre A., Vistnes M., Sjaastad I., Nygård S., Husberg C., Lunde I. G., Aukrust P., Yndestad A., Vinge L. E., Behmen D., Neukamm C., Brun H., Thaulow E., Christensen G., Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle. Journal of Applied Physiology 2012 112 8 1372 1382 2-s2.0-84860324636 10.1152/japplphysiol.01350.2011
25. Herder C., Illig T., Baumert J., Müller M., Klopp N., Khuseyinova N., Meisinger C., Poschen U., Martin S., Koenig W., Thorand B., RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. European Journal of Endocrinology 2008 158 5 R1 R5 2-s2.0-43149111488 10.1530/EJE-07-0686 (Pubitemid 351639618)
26. Yang S. J., Iglayreger H. B., Kadouh H. C., Bodary P. F., Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy. Diabetologia 2009 52 5 972 981 2-s2.0-64149125118 10.1007/s00125-009-1309-8
27. Liu S., Hoke D., Julian J., Carson D. D., Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS. Journal of Biological Chemistry 1997 272 41 25856 25862 2-s2.0-0030822522 10.1074/jbc.272.41.25856 (Pubitemid 27438910)
28. Kowluru R. A., Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Investigative Ophthalmology and Visual Science 2010 51 8 4320 4326 2-s2.0-77955865427 10.1167/iovs.09-4851
29. Zhang L., Li X., Bi L.-J., Alterations of collagen-I, MMP-1 and TIMP-1 in the periodontal ligament of diabetic rats under mechanical stress. Journal of Periodontal Research 2011 46 4 448 455 2-s2.0-79959607566 10.1111/j.1600-0765. 2011.01359.x
30. Schwenke M., Knöfler M., Velicky P., Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS One 2013 8 1 e54336
31. Pietro L., Daher S., Rudge M. V. C., Calderon I. M. P., Damasceno D. C., Sinzato Y. K., Bandeira C., Bevilacqua E., Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta 2010 31 9 770 780 2-s2.0-77956343746 10.1016/j.placenta.2010.07.003
32. Zhou Z., Wang J., Cao R., Morita H., Soininen R., Chan K. M., Liu B., Cao Y., Tryggvason K., Impaired angiogenesis, delayed wound healing and retarded tumor growth in Perlecan heparan sulfate-deficient mice. Cancer Research 2004 64 14 4699 4702 2-s2.0-3142682314 10.1158/0008-5472.CAN-04-0810 (Pubitemid 38924508)
33. D'Souza S., Yang W., Marchetti D., Muir C., Farach-Carson M. C., Carson D. D., HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. Journal of Cellular Biochemistry 2008 105 5 1183 1193 2-s2.0-57149114934 10.1002/jcb.21899
34. Whitelock J. M., Murdoch A. D., Iozzo R. V., Underwood P. A., The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. Journal of Biological Chemistry 1996 271 17 10079 10086 2-s2.0-0029876376 10.1074/jbc.271.17.10079 (Pubitemid 26131567)
35. Parish C. R., Heparan sulfate and inflammation. Nature Immunology 2005 6 9 861 862 2-s2.0-24944586023 10.1038/ni0905-861 (Pubitemid 43090436)
36. Cooper A., Tal G., Lider O., Shaul Y., Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. Journal of Immunology 2005 175 5 3165 3176 2-s2.0-23844455909 (Pubitemid 41170538)
37. Mummery R. S., Rider C. C., Characterization of the heparin-binding properties of IL-6. Journal of Immunology 2000 165 10 5671 5679 2-s2.0-0034669968
38. Taylor K. R., Gallo R. L., Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB Journal 2006 20 1 9 22 2-s2.0-30744451472 10.1096/fj.05-4682rev (Pubitemid 43100470)
39. Gori A. M., Attanasio M., Gazzini A., Rossi L., Lucarini L., Miletti S., Chini J., Manoni M., Abbate R., Gensini G. F., Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. Journal of Thrombosis and Haemostasis 2004 2 9 1657 1662 2-s2.0-19944432597 10.1111/j.1538-7836.2004.00866.x (Pubitemid 40186184)
40. Campo G. M., Avenoso A., Campo S., D'Ascola A., Traina P., Samá D., Calatroni A., Purified human plasma glycosaminoglycans reduced NF- B activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immunity 2008 14 4 233 246 2-s2.0-58949098173 10.1177/1753425908094725
41. Kuzmicki M., Telejko B., Szamatowicz J., Zonenberg A., Nikolajuk A., Kretowski A., Gorska M., High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecological Endocrinology 2009 25 4 258 263 2-s2.0-67650340287 10.1080/09513590802653825
42. AboElAsrar M. A., Elbarbary N. S., Elshennawy D. E., Omar A. M., Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density. Cytokine 2012 59 1 86 93 2-s2.0-84859645549 10.1016/j.cyto.2012.03.019